MR Imaging for Acute Stroke

详细信息    查看全文

• 作者：Jochen B. Fiebach (1)
  Ivana Galinovic (1)
  
  1. Division of Academic Neuroradiology ; Department of Neurology ; Center for Stroke Research Berlin (CSB) ; Charit茅-Universit盲tsmedizin Berlin ; Campus Benjamin Franklin ; Klinik f眉r Neurologie ; Raum 1252 ; Hindenburgdamm 30 ; 12200 ; Berlin ; Germany
  
• 关键词：Stroke ; Cerebral imaging ; MRI ; Thrombolysis ; FLAIR ; Diffusion weighted images ; Wake ; up stroke
• 刊名：Current Radiology Reports
• 出版年：2014
• 出版时间：June 2014
• 年：2014
• 卷：2
• 期：6
• 全文大小：1,125 KB
• 参考文献：1. Lees, KR, Bluhmki, E, Kummer, R, Bastianello, S (2010) Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375: pp. 1695-1703 CrossRef
  2. Moseley, ME, Mintorovitch, J, Cohen, Y (1990) Early detection of ischemic injury: comparison of spectroscopy, diffusion-, T2-, and magnetic susceptibility-weighted MRI in cats. Acta Neurochir Suppl (Wien) 51: pp. 207-209
  3. Warach, S, Gaa, J, Siewert, B (1995) Acute human stroke studied by whole brain echo planar diffusion weighted magnetic resonance imaging. Ann Neurol 37: pp. 231-241 CrossRef
  4. Kucinski, T, V盲terlein, O, Glauche, V (2002) Correlation of apparent diffusion coefficient and computed tomography density in acute ischemic stroke. Stroke 33: pp. 1786-1791 CrossRef
  5. Kummer, R, Bourquain, H, Bastianello, S (2001) Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology 219: pp. 95-100 CrossRef
  6. Benameur, K, Bykowski, JL, Luby, M (2006) Higher prevalence of cortical lesions observed in patients with acute stroke using high-resolution diffusion-weighted imaging. Am J Neuroradiol 27: pp. 1987-1989
  7. Sylaja, PN, Coutts, SB, Krol, A (2008) When to expect negative diffusion-weighted images in stroke and transient ischemic attack. Stroke 39: pp. 1898-1900 CrossRef
  8. 鈥?Hotter B, Kufner A, Malzahn U, et al. Validity of negative high-resolution diffusion-weighted imaging in transient acute cerebrovascular events. Stroke. 2013;44:2598鈥?00. / Hotter et al proofed that a negative hrDWI is accurate and does not require additional imaging if patient does not have any symptoms 24 h after index event.
  9. Kidwell, CS, Chalela, JA, Saver, JL (2004) Comparison of MRI and CT for detection of acute intracerebral hemorrhage. JAMA 292: pp. 1823-1830 CrossRef
  10. Fiebach, JB, Schellinger, PD, Gass, A (2004) Stroke magnetic resonance imaging is accurate in hyperacute intracerebral hemorrhage: a multicenter study on the validity of stroke imaging. Stroke 35: pp. 502-506 CrossRef
  11. 鈥?Neeb L, Villringer K, Galinovic I, et al. Adapting the computed tomography criteria of hemorrhagic transformation to stroke magnetic resonance imaging. Cerebrovasc Dis Extra. 2013;3(1):103鈥?0. / Neeb et al translated the CT based classification of hemorrhagic infarction to MRI.
  12. Greenberg, SM, Vernooij, MW, Cordonnier, C (2009) Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 8: pp. 165-174 CrossRef
  13. 鈥⑩€?Fiehler J, Albers GW, Boulanger JM, for the MR STROKE Group, et al. Bleeding risk analysis in stroke imaging before thromboLysis (BRASIL): pooled analysis of T2*-weighted magnetic resonance imaging data from 570 patients. Stroke. 2007;38(10):2738鈥?4. / Fiehler et al showed that microbleeds per se are not an exclusion criterion for thrombolysis.
  14. Warach, S, Dashe, JF, Edelman, RR (1996) Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: a preliminary analysis. J Cereb Blood Flow Metab 16: pp. 53-59 CrossRef
  15. Davis, SM, Donnan, GA, Butcher, KS, Parsons, M (2005) Selection of thrombolytic therapy beyond 3聽h using magnetic resonance imaging. Curr Opin Neurol 18: pp. 47-52 CrossRef
  16. Thomalla, G, Schwark, C, Sobesky, J (2006) Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke 37: pp. 852-858 CrossRef
  17. Hacke, W, Albers, G, Al-Rawi, Y (2005) The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36: pp. 66-73 CrossRef
  18. Kohrmann, M, Juttler, E, Fiebach, JB (2006) MRI versus CT-based thrombolysis treatment within and beyond the 3聽h time window after stroke onset: a cohort study. Lancet Neurol 5: pp. 661-667 CrossRef
  19. Warach, S, Al-Rawi, Y, Furlan, AJ (2012) Refinement of the magnetic resonance diffusion-perfusion聽mismatch concept for thrombolytic patient selection: insights from the desmoteplase in acute stroke trials. Stroke 43: pp. 2313-2318 CrossRef
  20. Galinovic, I, Ostwaldt, AC, Soemmer, C (2011) Search for a map and threshold in perfusion MRI to accurately predict tissue fate: a protocol for assessing lesion growth in patients with persistent vessel occlusion. Cerebrovasc Dis 32: pp. 186-193 CrossRef
  21. Butcher, KS, Parsons, M, MacGregor, L (2005) Refining the perfusion鈥揹iffusion mismatch hypothesis. Stroke 36: pp. 1153-1159 CrossRef
  22. Lansberg, MG, Straka, M, Kemp, S (2012) MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol 11: pp. 860-867 CrossRef
  23. Silva, DA, Churilov, L, Olivot, JM (2011) Greater effect of stroke thrombolysis in the presence of arterial obstruction. Ann Neurol 70: pp. 601-605 CrossRef
  24. Ma, L, Gao, PY, Lin, Y (2009) Can baseline magnetic resonance angiography (MRA) status become a foremost factor in selecting optimal acute stroke patients for recombinant tissue plasminogen activator (rt-PA) thrombolysis beyond 3 hours?. Neurol Res 31: pp. 355-361 CrossRef
  25. 鈥?Fiebach JB, Al-Rawi Y, Wintermark M, et al. Vascular occlusion enables selecting acute ischemic stroke patients for treatment with desmoteplase. Stroke. 2012;43(6):1561鈥?. / A post hoc analysis of the DSPA trials shows the importance of vessel status for therapeutic decisions.
  26. Ringleb, PA, Bousser, MG, Ford, G (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25: pp. 457-507 CrossRef
  27. 鈥?Hacke W, Donnan G, Fieschi C, for the ATLANTIS Trials Investigators and ECASS Trials Investigators. NINDS rt-PA Study Group Investigators, et al. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768鈥?4. / Pooled data of CT based thrombolysis trials shows a decline of efficacy over time.
  28. Lago, A, Geffner, D, Tembl, J (1998) Circadian variation in acute ischemic stroke: a hospital-based study. Stroke 29: pp. 1873-1875 CrossRef
  29. Serena, J, Davalos, A, Segura, T (2003) Stroke on awakening: looking for a more rational management. Cerebrovasc Dis 16: pp. 128-133 CrossRef
  30. Welch, KM, Windham, J, Knight, RA (1995) A model to predict the histopathology of human stroke using diffusion and T 2-weighted magnetic resonance imaging. Stroke 26: pp. 1983-1989 CrossRef
  31. Ebinger, M, Galinovic, I, Rozanski, M (2010) Fluid-attenuated inversion recovery evolution within 12 hours from stroke onset: a reliable tissue clock?. Stroke 41: pp. 250-255 CrossRef
  32. Lansberg, MG, Thijs, VN, O鈥橞rien, MW (2001) Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke. Am J Neuroradiol 22: pp. 637-644
  33. Thomalla, G, Rossbach, P, Rosenkranz, M (2009) Negative FLAIR imaging identifies acute ischemic stroke 鈮? hours. Ann Neurol 65: pp. 724-732 CrossRef
  34. Thomalla, G, Cheng, B, Ebinger, M (2011) DWI鈥揊LAIR mismatch for the identification of patients with acute ischaemic stroke within 4路5聽h of symptom onset (PRE-FLAIR): a multicentre observational study. Lancet Neurol 10: pp. 978-986 CrossRef
  35. Song, SS, Latour, LL, Ritter, CH (2012) A pragmatic approach using magnetic resonance imaging to treat ischemic strokes of unknown onset time in a thrombolytic trial. Stroke 43: pp. 2331-2335 CrossRef
  36. 鈥⑩€?Cheng B, Brinkmann M, Forkert ND, for the STIR and VISTA Imaging Investigators, et al. Quantitative measurements of relative fluid-attenuated inversion recovery (FLAIR) signal intensities in acute stroke for the prediction of time from symptom onset. J Cereb Blood Flow Metab. 2013;33:76鈥?4. / DWI-FLAIR mismatch聽indicates early brain ischemia and can be used to include wake-up stroke patients into thrombolysis trials.
  37. Aoki, J, Kimura, K, Iguchi, Y (2010) FLAIR can estimate the onset time in acute ischemic stroke patients. J Neurol Sci 293: pp. 39-44 CrossRef
  38. Thomalla G, Fiebach JB, Ostergaard L, et al. A multicenter, randomized, double-blind, placebo-controlled trial to test efficacy and safety of magnetic resonance imaging-based thrombolysis in wake-up stroke (WAKE-UP). Int J Stroke. 2013. doi:10.1111/ijs.12011 .
  
• 刊物主题：Imaging / Radiology;
• 出版者：Springer US
• ISSN：2167-4825

文摘

Cerebral imaging is essential to differentiate the pathologies behind acute stroke. Excluding hemorrhage with a native CT is a prerequisite before thrombolytic drugs can be administered. With stroke MRI, vessel occlusion, ischemia and infarction can be visualized. This detailed diagnostic information can facilitate the decision for or against thrombolysis. Analysis of FLAIR and diffusion-weighted images enables the identification of patients in an early time window after ictus and is currently used in randomized trials of wake-up stroke.